Profile
Bryan Michael DeChairo is currently an Independent Director at Biocartis Group NV since 2023, a Director at Sense Biodetection Ltd. since 2023, and will be Chief Operating Officer at GeneDx Holdings Corp.
starting in 2025.
Formerly, Dr. DeChairo was President, Chief Executive Officer & Director at Sherlock Biosciences, Inc. from 2021 to 2024.
Other former roles include Director-Molecular Medicine & Neuroscience Lead at Pfizer (St. Louis), Principal at Sequana Therapeutics, Inc., Executive Vice President-Clinical Development at Myriad Genetics, Inc. from 2012 to 2021, Head-Diagnostic Reimbursement Evaluation at Medco Health Solutions, Inc., Principal Scientist at Oxagen Ltd., Principal at Roche Molecular Systems, Inc., and Senior VP-Medical Affairs & Clinical Development at Assurex Health, Inc. from 2013 to 2017.
Education includes undergraduate studies at the University of California, Berkeley and a doctorate from University College London.
Bryan DeChairo active positions
| Companies | Position | Start |
|---|---|---|
| BIOCARTIS GROUP NV | Director/Board Member | 2023-02-20 |
| GENEDX HOLDINGS CORP. | Chief Operating Officer | 2025-01-01 |
Sense Biodetection Ltd.
Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Engages in molecular diagnostic testing | Director/Board Member | 2023-01-29 |
Former positions of Bryan DeChairo
| Companies | Position | End |
|---|---|---|
Sherlock Biosciences, Inc.
Sherlock Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops molecular diagnostics solutions | Chief Executive Officer | 2024-11-30 |
| MYRIAD GENETICS, INC. | Corporate Officer/Principal | 2021-03-31 |
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology Operates as a personalized medicine company | Chief Tech/Sci/R&D Officer | 2017-07-31 |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms | Corporate Officer/Principal | - |
Sequana Therapeutics, Inc.
Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops proprietary gene therapy products | Corporate Officer/Principal | - |
Training of Bryan DeChairo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Sequana Therapeutics, Inc.
Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops proprietary gene therapy products | Commercial Services |
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Medco Health Solutions, Inc.
Medco Health Solutions, Inc. Medical/Nursing ServicesHealth Services Provides healthcare, pharmacy and mobile application services | Health Services |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms | Health Services |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology Operates as a personalized medicine company | Health Technology |
Biocartis Group NV
Biocartis Group NV Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Health Technology |
Sense Biodetection Ltd.
Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Engages in molecular diagnostic testing | Health Services |
Sherlock Biosciences, Inc.
Sherlock Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops molecular diagnostics solutions | Health Technology |
GeneDx Holdings Corp.
GeneDx Holdings Corp. Medical/Nursing ServicesHealth Services Provides diagnostic genetic testing services | Health Services |
- Stock Market
- Insiders
- Bryan DeChairo
















